Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
25.16%
↑ 170% vs avg
Percentile
P100
Near historical high
Streak
5 yr
Consecutive growthAccelerating
Average
-35.81%
Historical baseline
PeriodValue
202525.16%
2024-5.62%
2023-7.07%
2022-8.62%
2021-93.55%
2020-109.05%
2019-87.71%
20180.00%